Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Open in Screener

PACB

Pacific Biosciences of California Inc

Jun 14 • 04:00PM ET

1.76

Dollar change -0.09
Percentage change -4.86	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: ARKK ARKG VTI VB IWM VBR VXF IBB SCHA IWO

Index	RUT	P/E	-	EPS (ttm)	-1.14	Insider Own	2.96%	Shs Outstand	267.74M	Perf Week	-12.44%
Market Cap	479.35M	Forward P/E	-	EPS next Y	-0.73	Insider Trans	-2.29%	Shs Float	264.29M	Perf Month	-17.95%
Income	-296.90M	PEG	-	EPS next Q	-0.23	Inst Own	92.34%	Short Float	20.53%	Perf Quarter	-53.56%
Sales	200.43M	P/S	2.39	EPS this Y	23.50%	Inst Trans	-6.30%	Short Ratio	5.21	Perf Half Y	-80.14%
Book/sh	2.38	P/B	0.74	EPS next Y	21.10%	ROA	-16.65%	Short Interest	54.25M	Perf Year	-86.66%
Cash/sh	2.06	P/C	0.85	EPS next 5Y	-1.00%	ROE	-44.28%	52W Range	1.25 - 14.55	Perf YTD	-82.06%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-9.76%	ROI	-18.90%	52W High	-87.90%	Beta	2.08
Dividend TTM	-	Quick Ratio	8.36	Sales past 5Y	24.48%	Gross Margin	17.49%	52W Low	40.80%	ATR (14)	0.22
Dividend Ex-Date	-	Current Ratio	9.28	EPS Y/Y TTM	18.48%	Oper. Margin	-156.06%	RSI (14)	42.81	Volatility	7.70% 9.73%
Employees	796	Debt/Eq	1.44	Sales Y/Y TTM	49.54%	Profit Margin	-148.13%	Recom	2.13	Target Price	3.33
Option/Short	Yes / Yes	LT Debt/Eq	1.42	EPS Q/Q	20.24%	Payout	-	Rel Volume	0.63	Prev Close	1.85
Sales Surprise	-10.66%	EPS Surprise	-5.26%	Sales Q/Q	-0.23%	Earnings	May 09 AMC	Avg Volume	10.41M	Price	1.76
SMA20	-8.23%	SMA50	-13.49%	SMA200	-71.03%	Trades		Volume	6,562,522	Change	-4.86%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-03-24	Resumed	Jefferies	Buy	$4
Apr-22-24	Downgrade	JP Morgan	Overweight → Neutral
Apr-18-24	Downgrade	Goldman	Buy → Neutral	$7 → $2.50
Dec-14-23	Initiated	Stephens	Overweight	$11
Dec-14-23	Initiated	Guggenheim	Neutral
Dec-13-23	Initiated	Wolfe Research	Peer Perform
Nov-17-23	Upgrade	UBS	Neutral → Buy	$13 → $10
Oct-31-23	Upgrade	Cantor Fitzgerald	Neutral → Overweight	$11
Sep-28-23	Initiated	Bernstein	Outperform	$11
Jul-05-23	Resumed	JP Morgan	Overweight	$13
Jun-30-23	Initiated	Goldman	Buy	$17
May-10-23	Initiated	Barclays	Equal Weight	$14
Mar-31-23	Upgrade	TD Cowen	Market Perform → Outperform	$13 → $15
Feb-02-23	Initiated	UBS	Neutral	$13
Jan-20-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral	$12
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$12
Jan-21-22	Resumed	Cantor Fitzgerald	Overweight	$62 → $31
Jan-06-22	Resumed	Piper Sandler	Neutral	$20
Oct-15-21	Resumed	Cowen	Market Perform	$30
Sep-27-21	Initiated	Canaccord Genuity	Buy	$45

Show Previous Ratings

Jun-10-24 09:05AM	PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database (PR Newswire) -5.97%
May-29-24 01:00PM	Reasons to Retain PacBio (PACB) Stock in Your Portfolio (Zacks)
May-27-24 08:00AM	Why Cathie Wood Thinks Stock Fears Are At 'Depression' Levels (Investor's Business Daily)
May-23-24 09:00AM	Pacific Biosciences of California, Inc. (PACB) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
May-15-24 11:53AM	Pacific Biosciences, Ambry Genetics Selected to Sequence up to 7,000 Human Genomes (MT Newswires)
10:48AM	Loading…
10:48AM	Morgan Stanley Adjusts Price Target on Pacific Biosciences of California to $4 From $10, Maintains Equal-Weight Rating (MT Newswires)
09:45AM	Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases (PR Newswire)
May-14-24 03:46AM	Pacific Biosciences to lay off 195 employees as part of cost cuts (MedTech Dive) +15.54%
May-13-24 09:47AM	Piper Sandler Adjusts Price Target on Pacific Biosciences of California to $2 From $6.50, Maintains Neutral Rating (MT Newswires) +9.04%
May-10-24 06:32PM	Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2024 Earnings Call Transcript (Insider Monkey)
02:43PM	Pacific Biosciences of California Inc (PACB) Q1 2024 Earnings: Narrowing Losses but Misses ... (GuruFocus.com)
11:16AM	PacBio (PACB) Q1 Earnings In Line, Adjusted Gross Margin Up (Zacks)
May-09-24 08:55PM	PACB Stock Earnings: Pacific Biosciences Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
06:30PM	Pacific Biosciences (PACB) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
06:10PM	Pacific Biosciences of California (PACB) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
05:04PM	Loading…
05:04PM	Pacific Biosciences: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces First Quarter 2024 Financial Results (PR Newswire)
May-07-24 12:12PM	Soft Instrument Orders Likely to Hurt PacBio's (PACB) Q1 Earnings (Zacks) -6.03%
May-02-24 09:00AM	Investors Heavily Search Pacific Biosciences of California, Inc. (PACB): Here is What You Need to Know (Zacks)
Apr-25-24 09:35AM	Here's Why Pacific Biosciences (PACB) is Poised for a Turnaround After Losing -63.44% in 4 Weeks (Zacks)
Apr-23-24 12:00PM	Pacific Biosciences (PACB) Upgraded to Buy: Here's What You Should Know (Zacks) -5.77%
Apr-17-24 01:00PM	PacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays (Zacks)
Apr-16-24 02:47PM	The Cathie Wood Stock Shuffle: 4 Names Shes Loving, 3 Shes Leaving (InvestorPlace) -50.62%
08:05AM	PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance (PR Newswire)
Apr-03-24 10:54AM	Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now (Zacks)
Mar-27-24 08:00AM	Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes (PR Newswire) +5.68%
Mar-22-24 04:30PM	PacBio Grants Equity Incentive Award to New Employee (PR Newswire)
Mar-13-24 03:32PM	11 Oversold NASDAQ Stocks To Buy Right Now (Insider Monkey) +5.74%
10:17AM	PacBio's (PACB) New Panel to Aid Its Clinical Research Solution (Zacks)
Mar-12-24 09:05AM	PacBio Announces PureTarget Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions (PR Newswire) -8.86%
11:57PM	Loading…
Mar-06-24 11:57PM	Director David Meline Acquires 40,000 Shares of Pacific Biosciences of California Inc (PACB) (GuruFocus.com)
Feb-27-24 03:30AM	12 Best Medical Stocks to Buy Under $10 (Insider Monkey) +7.46%
Feb-26-24 04:05PM	PacBio to Present at Upcoming Investor Conferences (PR Newswire)
Feb-25-24 07:04AM	14 Best Beaten Down Stocks To Buy Right Now (Insider Monkey)
Feb-22-24 04:21AM	13 Best Falling Stocks To Buy Right Now (Insider Monkey)
Feb-16-24 10:50AM	PacBio (PACB) Q4 Earnings Beat, Adjusted Gross Margin Down (Zacks) -13.94%
08:59AM	Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:34AM	Q4 2023 Pacific Biosciences of California Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-15-24 06:30PM	Pacific Biosciences (PACB) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:30PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:43PM	Pacific Biosciences of California Inc (PACB) Reports Substantial Revenue Growth Amidst Widening ... (GuruFocus.com)
04:28PM	Pacific Biosciences: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results (PR Newswire)
Feb-13-24 07:00AM	Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch (PR Newswire) -9.39%
Feb-10-24 05:09PM	Top 11 CRISPR Stocks To Invest In (Insider Monkey)
Feb-06-24 09:41AM	PacBio's (PACB) New Kits to Boost Its Revio Sequencing System (Zacks)
Feb-05-24 09:05AM	PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale (PR Newswire)
Jan-25-24 04:03PM	PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024 (PR Newswire)
Jan-16-24 12:13PM	PacBio's (PACB) New PanDNA Kit Ready to Boost DNA Extraction (Zacks)
Jan-15-24 09:05AM	PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions (PR Newswire)
Jan-11-24 10:00AM	TurnCare, Inc. Announces John F. Milligan, PhD, former CEO of Gilead Sciences, joins Board of Directors (PR Newswire) -12.06%
Jan-09-24 10:43AM	PacBio (PACB) Preliminary Q4 Revenues Boosted by Revio Sales (Zacks)
Jan-08-24 08:00AM	PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively (PR Newswire) -18.51%
Dec-27-23 04:05PM	PacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-26-23 08:24AM	Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now (Zacks)
Dec-20-23 01:50PM	12 Most Promising Gene Editing Stocks According to Hedge Funds (Insider Monkey)
Dec-11-23 08:00AM	PacBio Announces the Retirement of David Botstein, Ph.D., from its Board of Directors (PR Newswire)
Dec-10-23 04:00PM	The 3 Best Cathie Wood Stocks to Buy in December (InvestorPlace)
11:59AM	12 Best Genomics Stocks To Buy Now (Insider Monkey)
Nov-10-23 09:30AM	Compared to Estimates, Pacific Biosciences (PACB) Q3 Earnings: A Look at Key Metrics (Zacks)
Nov-09-23 04:10PM	PacBio to Present at Upcoming Investor Conferences (PR Newswire)
Nov-02-23 09:05AM	PacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders (PR Newswire) +9.21%
Nov-01-23 09:05AM	PacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible (PR Newswire)
Oct-31-23 11:35AM	PacBio (PACB) Tops on Q3 Earnings, Raises FY23 Revenue View (Zacks) -13.08%
09:34AM	Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q3 2023 Earnings Call Transcript (Insider Monkey)
09:05AM	PacBio Announces Kinnex RNA Kits, Further Scaling HiFi Sequencing in Full-Length RNA, Single-Cell RNA and 16S rRNA Applications (PR Newswire)
Oct-30-23 06:00PM	Pacific Biosciences of California Inc (PACB) Reports Q3 2023 Earnings: Revenue Up 72% YoY (GuruFocus.com)
04:19PM	Pacific Biosciences: Q3 Earnings Snapshot (Associated Press Finance)
04:03PM	PacBio Announces Third Quarter 2023 Financial Results (PR Newswire)
03:46PM	Top 20 Genomics Companies in the World (Insider Monkey)
Oct-18-23 05:52AM	Cathie Wood Just Added $5 Million of This Stock After It Had a Steep Pullback. Is It a No-Brainer Buy? (Motley Fool) -6.82%
Oct-17-23 10:04AM	PacBio's (PACB) New Offering to Boost WGS Data Analysis (Zacks)
Oct-16-23 10:43AM	16 Best Stocks to Buy and Hold for the Next 15 Years According to Cathie Woods Portfolio (Insider Monkey)
08:05AM	PacBio Announces Appointment of David Meline to Board of Directors (PR Newswire)
Oct-12-23 04:03PM	PacBio to Report Third Quarter 2023 Financial Results on October 30, 2023 (PR Newswire) -10.96%
Oct-11-23 09:05AM	PacBio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis (PR Newswire)
Oct-06-23 12:11PM	Three Reasons to Add PacBio (PACB) Stock to Your Portfolio (Zacks)
Sep-19-23 12:07PM	Unraveling the Challenges Ahead for Pacific Biosciences of California Inc (PACB) (GuruFocus.com)
Sep-18-23 11:55AM	Is Pacific Biosciences of California (PACB) Too Good to Be True? A Comprehensive Analysis of a ... (GuruFocus.com) -7.10%
Sep-14-23 12:56PM	Unveiling Pacific Biosciences of California (PACB)'s Value: Is It Really Priced Right? A ... (GuruFocus.com) -6.06%
12:32PM	Unraveling the Challenges Ahead for Pacific Biosciences of California Inc (PACB) (GuruFocus.com)
07:30AM	Strength Seen in Pacific Biosciences (PACB): Can Its 8.9% Jump Turn into More Strength? (Zacks)
Sep-13-23 12:48PM	Pacific Biosciences of California Stock Clears Key Benchmark, Hitting 80-Plus RS Rating (Investor's Business Daily) +8.92%
Sep-12-23 08:00AM	PacBio Announces PacBio Capital (PR Newswire)
Sep-08-23 07:23AM	Cathie Wood's Buying These 3 Stocks Hand Over Fist (Motley Fool)
Sep-07-23 09:05AM	PacBio Announces Collaboration with Leading Library Preparation Automation Partners (PR Newswire)
Sep-05-23 12:25PM	Here's Why You Should Retain PacBio (PACB) Stock for Now (Zacks)
09:52AM	Market May Be Broadening Out: Cathie Wood Loads Up on These 2 Innovation Stocks (TipRanks)
Aug-09-23 04:03PM	PacBio to Present at Upcoming Investor Conferences (PR Newswire)
10:00AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
08:16AM	PacBio (PACB) Inks Research Collaboration for Genome Sequencing (Zacks)
Aug-07-23 09:18AM	Time to Nail Down Profits in One of My Top Picks (TheStreet.com)
08:00AM	PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care (PR Newswire)
Aug-04-23 07:20PM	PacBio Reports Equity Incentive Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire) +5.73%
08:30AM	Pacific Biosciences of California, Inc.'s (NASDAQ:PACB) P/S Is On The Mark (Simply Wall St.)
Aug-03-23 01:16PM	PacBio (PACB) Tops on Q2 Earnings, Raises FY23 Revenue View (Zacks) -7.99%
Aug-02-23 06:15PM	Pacific Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -6.15%
05:06PM	Pacific Biosciences: Q2 Earnings Snapshot (AP Finance)
04:06PM	PacBio Announces Second Quarter 2023 Financial Results (PR Newswire)
04:04PM	PacBio Enters into Agreement to Acquire Apton Biosystems to Accelerate the Development of a Next Generation, High Throughput, Short-read Sequencer (PR Newswire)

Pacific Biosciences of California, Inc. engages in the development, manufacture, and marketing of advanced sequencing solutions for genetic analysis. It operates through the following geographical segments: America, Europe, Middle East, and Africa, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Farmer Michele	See Remarks	May 20 '24	Sale	2.03	5,275	10,708	211,941	May 22 05:25 PM
ORDONEZ KATHY	Director	Mar 15 '24	Option Exercise	2.87	361,621	1,038,682	380,216	Mar 19 04:24 PM
Meline David W	Director	Mar 06 '24	Buy	4.40	40,000	176,160	40,000	Mar 06 05:36 PM
HENRY CHRISTIAN O	See Remarks	Mar 04 '24	Sale	4.87	14,177	69,056	2,596,670	Mar 06 05:12 PM
Van Oene Mark	See Remarks	Mar 04 '24	Sale	4.87	9,186	44,745	1,668,826	Mar 06 05:26 PM
Kim Susan G.	See Remarks	Mar 04 '24	Sale	4.87	5,275	25,695	712,260	Mar 06 05:22 PM
Farmer Michele	See Remarks	Mar 04 '24	Sale	4.87	2,968	14,457	217,216	Mar 06 05:30 PM
MOHR MARSHALL	Director	Mar 01 '24	Option Exercise	4.45	25,000	111,250	110,000	Mar 05 04:27 PM
HENRY CHRISTIAN O	See Remarks	Feb 20 '24	Sale	5.26	1,979	10,412	1,005,078	Feb 21 06:14 PM
Kim Susan G.	See Remarks	Feb 20 '24	Sale	5.26	831	4,372	282,758	Feb 21 06:17 PM
HENRY CHRISTIAN O	See Remarks	Feb 16 '24	Sale	5.96	79,038	470,908	1,007,057	Feb 21 06:14 PM
Van Oene Mark	See Remarks	Feb 16 '24	Sale	5.96	33,560	199,950	876,611	Feb 21 06:25 PM
Kim Susan G.	See Remarks	Feb 16 '24	Sale	5.96	22,496	134,031	283,589	Feb 21 06:17 PM
Eidel Jeff	See Remarks	Feb 16 '24	Sale	5.96	15,498	92,337	431,824	Feb 21 06:20 PM
Farmer Michele	See Remarks	Feb 16 '24	Sale	5.96	7,562	45,054	101,164	Feb 21 06:07 PM
Van Oene Mark	See Remarks	Jan 09 '24	Sale	7.77	31,012	241,056	910,171	Jan 10 05:44 PM
HENRY CHRISTIAN O	See Remarks	Dec 14 '23	Sale	10.00	20,000	200,000	1,086,095	Dec 15 04:35 PM
Kim Susan G.	See Remarks	Sep 29 '23	Sale	8.44	19,257	162,471	306,085	Sep 29 06:47 PM
HENRY CHRISTIAN O	See Remarks	Sep 18 '23	Sale	10.12	96,844	980,255	1,106,095	Sep 19 04:32 PM
HENRY CHRISTIAN O	See Remarks	Sep 11 '23	Sale	10.45	10,000	104,520	1,202,939	Sep 12 04:42 PM
Eidel Jeff	See Remarks	Aug 17 '23	Sale	10.60	25,936	274,844	444,666	Aug 18 04:36 PM
HENRY CHRISTIAN O	See Remarks	Aug 17 '23	Sale	10.50	10,000	105,000	1,212,939	Aug 18 04:44 PM
Van Oene Mark	See Remarks	Aug 16 '23	Sale	11.00	26,102	287,122	939,769	Aug 18 04:26 PM

Open in Screener

MRNA

Moderna Inc

Jun 14 • 04:00PM ET

140.03

Dollar change -5.20
Percentage change -3.58	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VTI QQQ VOO VO SPY IVV VUG IBB XLV VOT

Index	NDX, S&P 500	P/E	-	EPS (ttm)	-15.68	Insider Own	12.10%	Shs Outstand	382.00M	Perf Week	-7.27%
Market Cap	53.67B	Forward P/E	-	EPS next Y	-5.40	Insider Trans	-1.26%	Shs Float	337.07M	Perf Month	8.50%
Income	-5968.00M	PEG	-	EPS next Q	-3.36	Inst Own	67.35%	Short Float	5.99%	Perf Quarter	34.84%
Sales	5.14B	P/S	10.43	EPS this Y	42.72%	Inst Trans	0.89%	Short Ratio	5.15	Perf Half Y	78.16%
Book/sh	33.46	P/B	4.18	EPS next Y	23.54%	ROA	-29.22%	Short Interest	20.18M	Perf Year	11.09%
Cash/sh	22.28	P/C	6.28	EPS next 5Y	-	ROE	-37.68%	52W Range	62.55 - 170.47	Perf YTD	40.80%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-20.02%	ROI	-42.54%	52W High	-17.86%	Beta	1.69
Dividend TTM	-	Quick Ratio	3.91	Sales past 5Y	662.08%	Gross Margin	11.10%	52W Low	123.87%	ATR (14)	8.03
Dividend Ex-Date	-	Current Ratio	4.03	EPS Y/Y TTM	-227.99%	Oper. Margin	-100.04%	RSI (14)	48.47	Volatility	4.52% 6.37%
Employees	5600	Debt/Eq	0.10	Sales Y/Y TTM	-65.53%	Profit Margin	-116.00%	Recom	2.48	Target Price	143.53
Option/Short	Yes / Yes	LT Debt/Eq	0.09	EPS Q/Q	-1676.58%	Payout	-	Rel Volume	0.92	Prev Close	145.23
Sales Surprise	79.07%	EPS Surprise	13.68%	Sales Q/Q	-91.07%	Earnings	May 02 BMO	Avg Volume	3.92M	Price	140.03
SMA20	-6.12%	SMA50	10.33%	SMA200	36.24%	Trades		Volume	3,598,153	Change	-3.58%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-26-24	Downgrade	HSBC Securities	Hold → Reduce	$75 → $86
Jan-02-24	Upgrade	Oppenheimer	Perform → Outperform	$142
Nov-29-23	Initiated	Canaccord Genuity	Hold	$82
Nov-03-23	Upgrade	HSBC Securities	Reduce → Hold	$89 → $69
Nov-02-23	Downgrade	Deutsche Bank	Hold → Sell	$125 → $60
Aug-04-23	Downgrade	TD Cowen	Outperform → Market Perform	$145 → $125
Aug-03-23	Downgrade	Deutsche Bank	Buy → Hold	$125
Jul-24-23	Initiated	William Blair	Mkt Perform	$136.28
Jul-14-23	Initiated	HSBC Securities	Reduce	$97
Jun-26-23	Upgrade	UBS	Neutral → Buy	$221 → $191
Apr-26-23	Initiated	Guggenheim	Neutral
Mar-13-23	Upgrade	TD Cowen	Market Perform → Outperform	$150 → $180
Mar-02-23	Initiated	RBC Capital Mkts	Outperform	$200
Feb-24-23	Downgrade	SVB Securities	Market Perform → Underperform	$111 → $93
Dec-19-22	Upgrade	Jefferies	Hold → Buy	$170 → $275
Dec-14-22	Downgrade	Chardan Capital Markets	Buy → Neutral	$186 → $191
Oct-21-22	Upgrade	SVB Leerink	Underperform → Mkt Perform	$174 → $101
Sep-08-22	Upgrade	Deutsche Bank	Hold → Buy	$165
Feb-01-22	Upgrade	Redburn	Sell → Neutral
Jan-26-22	Upgrade	Deutsche Bank	Sell → Hold	$175

Show Previous Ratings

Today 09:45AM	Moderna Just Gave Investors Another Reason to Buy the Stock (Motley Fool)
Jun-15-24 01:54AM	Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal (Zacks)
Jun-14-24 05:00AM	JPMorgan's Ozempic bet, J&J's baby powder settlement, Moderna's COVID-flu vax: Pharma news round up (Quartz)
04:32AM	Modernas Covid-19 vaccine meets primary efficacy endpoint in Phase III trial (Clinical Trials Arena)
Jun-13-24 07:07AM	Moderna says next-gen COVID shot effective in study (BioPharma Dive)
07:00AM	Loading…
07:00AM	Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company's Next Generation COVID-19 Vaccine (ACCESSWIRE)
Jun-12-24 01:47PM	Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval? (Investor's Business Daily)
12:30PM	7 Struggling Stocks to Sell Before July 2024 (InvestorPlace)
11:53AM	Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine (Clinical Trials Arena)
07:00AM	Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer (PR Newswire)
Jun-11-24 11:53AM	Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data (Yahoo Finance)
10:10AM	Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal (Zacks)
06:00AM	3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants (InvestorPlace)
Jun-10-24 05:50PM	Moderna (MRNA) Stock Sinks As Market Gains: Here's Why (Zacks)
04:05PM	Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK (Investor's Business Daily)
01:27PM	Loading…
01:27PM	Stocks to Watch Monday: Nvidia, Apple, AMD, Southwest Airlines (The Wall Street Journal)
10:53AM	Moderna's COVID-flu combo shot outperformed existing vaccines in a late-stage trial (Quartz)
10:38AM	Moderna CEO on side effects of combination vaccine (CNBC TV)
09:40AM	Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review (Zacks)
08:26AM	Moderna says combination flu, COVID shot succeeds in study (BioPharma Dive)
08:24AM	Moderna's combination flu (CNBC TV)
07:32AM	Midday movers: Southwest Airlines, CrowdStrike, KKR rise; AMD falls (Investing.com)
06:30AM	Moderna Combination Shot Outperforms Standalone Flu, Covid-19 Jabs (Barrons.com)
06:30AM	Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19 (ACCESSWIRE)
05:50AM	Why Moderna Stock Is a No-Brainer Buy Right Now (Motley Fool)
Jun-08-24 06:45AM	3 Reasons to Buy Moderna Stock (Motley Fool)
Jun-07-24 12:05PM	Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season (Benzinga)
10:30AM	Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine (ACCESSWIRE)
05:00AM	Ozempic competitors, psychedelic stocks, and Moderna after COVID: Pharma news roundup (Quartz)
Jun-06-24 04:37PM	Novavax's stock surges almost 300% in the past month (Yahoo Finance)
11:38AM	Loading…
11:38AM	New Covid Boosters Get a Thumbs-Up From FDA. Vaccine Stocks Are Wavering. (Barrons.com)
10:05AM	Stocks to Watch Thursday: Lululemon, Nvidia, TSM, Five Below (The Wall Street Journal)
09:28AM	Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock? (InvestorPlace)
07:47AM	mRESVIAs FDA approval paves the way for mRNA vaccines across multiple indications (Clinical Trials Arena)
07:00AM	Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food & Drug Administration for START Pilot Program (ACCESSWIRE)
06:26AM	Data needed to forge the link between AI and mRNA (Pharmaceutical Technology)
Jun-05-24 05:37PM	Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential (InvestorPlace) +6.54%
05:02PM	S&P 500 Gains and Losses Today: Tech Outperformance Boosts Index to Record High (Investopedia)
Jun-04-24 01:45PM	Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon (Benzinga)
06:00AM	The 3 Most Undervalued Biotech Stocks to Buy in June 2024 (InvestorPlace)
04:25AM	Moderna and MSD share encouraging three-year data from trial of melanoma therapy (Clinical Trials Arena)
Jun-03-24 04:30PM	Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now? (Insider Monkey)
04:17PM	9 Best Gene Therapy Stocks to Buy Now (Insider Monkey)
03:41PM	FDA considers updating COVID boosters, Novavax stock reacts (Yahoo Finance Video)
03:06PM	Promising trial data for Moderna's skin cancer vaccine sends stock rising (Quartz)
12:27PM	Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma Patients (Benzinga)
09:44AM	Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine (Zacks)
08:00AM	Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survival Versus KEYTRUDA in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection (ACCESSWIRE)
06:07AM	Is Moderna Stock a Buy Now That It's a 2-Product Company? (Motley Fool)
04:50AM	Moderna Investors Just Got Some Bullish News (Motley Fool)
04:25AM	FDA approves Modernas RSV vaccine mRESVIA (Pharmaceutical Technology)
May-31-24 05:01PM	S&P 500 Gains and Losses Today: Caesars Entertainment Jumps on News of Icahn Stake (Investopedia) -5.90%
03:16PM	Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine (Benzinga)
02:39PM	Analyst Report: Moderna, Inc. (Morningstar Research)
12:10PM	Moderna just got FDA approval for its RSV vaccine only its second product on the market (Quartz)
12:07PM	Moderna Looks for Boost From Newly Approved RSV Shot (The Wall Street Journal)
11:53AM	Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK (Investor's Business Daily)
10:58AM	Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R) (ACCESSWIRE)
08:30AM	Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine? (Investor's Business Daily)
08:10AM	Jim Cramer's 10 Stock Picks Heading Into June (Insider Monkey)
08:04AM	Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2023 Earnings Call Transcript (Insider Monkey)
07:07AM	Moderna wins FDA approval for RSV vaccine (BioPharma Dive)
07:00AM	3 Sorry Biotech Stocks to Sell in May While You Still Can (InvestorPlace)
05:00AM	Ozempic supply trackers, bird flu vaccines, and Merck's future: Pharma news roundup (Quartz)
May-30-24 04:21PM	Why Moderna Stock Is Sinking This Week (Motley Fool)
04:03PM	The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive (Investor's Business Daily)
11:44AM	The U.S. Government Is Close To Bankrolling Moderna's Bird Flu Jab, But Shares Dip (Investor's Business Daily)
10:50AM	Moderna's mRNA bird flu vaccine trial is close to getting US government funding (Quartz)
09:22AM	Moderna Pops After Confirming The U.S. Government Could Back Its Bird Flu Vaccine (Investor's Business Daily)
08:30AM	Option Trade On Volatile Moderna Stock Could Return 28% By Mid-July (Investor's Business Daily)
07:39AM	Midday movers: Salesforce, Kohl's and Agilent fall; Foot Locker, HP rise (Investing.com)
06:00AM	3 Nasdaq Stocks to Dump as They Near Peak Performance (InvestorPlace)
May-29-24 11:56AM	The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why. (Barrons.com)
10:49AM	Moderna Stock Is Having Another Very Bad Day. Heres Why. (Barrons.com)
06:30AM	If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names (InvestorPlace)
May-28-24 04:56PM	S&P 500 Gains and Losses Today: Nvidia Stock Boosted by Elon Musk's xAI Venture (Investopedia) -8.05%
04:25PM	Moderna Stock Had a Very Bad Day. Heres Why. (Barrons.com)
04:09PM	Moderna Shares Had a Bad Day (Barrons.com)
10:38AM	Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why (Zacks)
07:00AM	Moderna Makes Big Play for Big Tech Talent (The Wall Street Journal)
May-27-24 06:28PM	Institutional Investors are Betting on Roivant Sciences (NASDAQ:ROIV) (Insider Monkey)
May-26-24 06:50AM	Should You Buy This Stock After a Regulatory Setback? (Motley Fool)
May-25-24 11:10PM	20 Biggest Publicly Traded Biotech Companies (Insider Monkey)
May-24-24 09:08PM	Lightning Round: Moderna, Comfort System USA, Sunoco, Celestica and AMC (CNBC TV)
12:00PM	Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know. (Barrons.com)
08:15AM	Why Vaccine Stocks Rallied This Week (Motley Fool)
May-23-24 12:45PM	Heard on the Street: Moderna Got a Boost From Bird Flu, but Dont Count Your Chicks (The Wall Street Journal)
11:34AM	The Moderna News That Has MRNA Stock Price Surging This Week: 3 Key Catalysts (InvestorPlace)
May-22-24 06:43PM	Second US Human Bird Flu Infection Reported in Michigan (Bloomberg) +13.67%
06:18PM	Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine (Barrons.com)
05:28PM	CDC Confirms a Second Bird Flu Case in U.S. Dairy Worker. Vaccine Momentum Builds. (Barrons.com)
05:12PM	Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks (Bloomberg)
04:48PM	S&P 500 Gains and Losses Today: Target Falls Amid Constrained Consumer Spending (Investopedia)
03:40PM	Moderna Stock Spikes on Bird Flu Worries (Barrons.com)
01:26PM	Nvidia earnings on tap, stocks in wait-and-see mode: Yahoo Finance (Yahoo Finance Video)
07:10AM	Moderna Has Big AI News. Is the Stock a Buy? (Motley Fool)
07:00AM	Moderna Announces Data to be Presented at 2024 ASCO Annual Meeting (ACCESSWIRE)
May-21-24 01:55PM	Final Trades: Moderna, Palantir, Oracle and Bank of America (CNBC TV)
01:34PM	3 Cathie Wood Stocks to Buy Now: May 2024 (InvestorPlace)
10:24AM	ChatGPT Parent Open AI Partners With Sanofi, Formation Bio To Boost AI-Driven Drug Development (Benzinga)

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
AFEYAN NOUBAR	Director	Jun 12 '24	Sale	147.20	15,000	2,208,071	2,314,015	Jun 14 07:00 PM
AFEYAN NOUBAR	Director	Jun 11 '24	Sale	148.34	202,832	30,087,339	1,528,557	Jun 11 07:01 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 10 '24	Sale	148.09	5,178	766,785	15,947	Jun 11 04:05 PM
AFEYAN NOUBAR	Director	Jun 05 '24	Sale	151.25	15,000	2,268,804	1,946,931	Jun 07 07:00 PM
Mock James M	Chief Financial Officer	Jun 03 '24	Sale	140.72	691	97,237	6,506	Jun 04 05:27 PM
Hoge Stephen	President	Jun 03 '24	Sale	140.72	339	47,704	1,472,089	Jun 04 05:20 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 03 '24	Sale	140.72	122	17,168	10,878	Jun 04 05:12 PM
AFEYAN NOUBAR	Director	May 29 '24	Sale	145.08	20,000	2,901,585	1,961,931	May 31 07:00 PM
Hoge Stephen	President	May 29 '24	Sale	144.50	341	49,276	1,471,777	May 30 04:14 PM
Mock James M	Chief Financial Officer	May 29 '24	Sale	144.50	183	26,444	5,871	May 30 04:36 PM
Klinger Shannon Thyme	Chief Legal Officer	May 29 '24	Sale	144.50	183	26,444	10,768	May 30 04:27 PM
Klinger Shannon Thyme	Chief Legal Officer	May 28 '24	Sale	162.47	1,296	210,566	10,623	May 29 04:12 PM
Mock James M	Chief Financial Officer	May 28 '24	Sale	162.47	648	105,283	5,726	May 29 04:16 PM
AFEYAN NOUBAR	Director	May 22 '24	Sale	157.57	15,000	2,363,556	1,981,931	May 24 07:00 PM
Hoge Stephen	President	May 15 '24	Sale	127.49	15,000	1,912,350	1,471,508	May 17 04:04 PM
AFEYAN NOUBAR	Director	May 15 '24	Sale	127.32	15,000	1,909,863	1,996,931	May 17 07:00 PM
Hoge Stephen	President	May 10 '24	Sale	120.96	255	30,844	1,486,508	May 13 04:03 PM
AFEYAN NOUBAR	Director	May 08 '24	Sale	121.68	15,000	1,825,220	2,011,931	May 10 07:00 PM
AFEYAN NOUBAR	Director	May 01 '24	Sale	110.92	15,000	1,663,855	2,026,931	May 03 07:00 PM
AFEYAN NOUBAR	Director	Apr 24 '24	Sale	108.32	15,000	1,624,836	2,041,931	Apr 26 07:00 PM
AFEYAN NOUBAR	Director	Apr 17 '24	Sale	103.38	15,000	1,550,703	2,056,931	Apr 19 07:00 PM
Hoge Stephen	President	Apr 15 '24	Sale	105.02	15,000	1,575,300	1,486,241	Apr 16 04:23 PM
AFEYAN NOUBAR	Director	Apr 10 '24	Sale	107.12	15,000	1,606,865	2,071,931	Apr 12 07:00 PM
Mock James M	Chief Financial Officer	Apr 08 '24	Sale	101.93	705	71,859	5,048	Apr 09 04:09 PM
AFEYAN NOUBAR	Director	Apr 03 '24	Sale	101.68	15,000	1,525,268	2,086,931	Apr 05 07:00 PM
AFEYAN NOUBAR	Director	Mar 27 '24	Sale	109.06	15,000	1,635,864	2,101,931	Mar 29 07:00 PM
AFEYAN NOUBAR	Director	Mar 20 '24	Sale	102.39	15,000	1,535,820	2,116,931	Mar 22 07:00 PM
Hoge Stephen	President	Mar 15 '24	Sale	103.17	15,000	1,547,550	1,501,241	Mar 19 04:39 PM
AFEYAN NOUBAR	Director	Mar 13 '24	Sale	108.54	15,000	1,628,031	2,131,931	Mar 15 07:00 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 08 '24	Sale	99.05	544	53,884	9,267	Mar 11 09:05 AM
Hoge Stephen	President	Mar 04 '24	Sale	94.34	309	29,151	1,516,241	Mar 05 05:52 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 04 '24	Sale	94.34	117	11,038	8,673	Mar 05 05:56 PM
Hoge Stephen	President	Feb 29 '24	Sale	94.57	2,388	225,838	1,515,898	Mar 01 05:25 PM
Klinger Shannon Thyme	Chief Legal Officer	Feb 29 '24	Sale	94.57	670	63,363	8,557	Mar 01 05:29 PM
Mock James M	Chief Financial Officer	Feb 29 '24	Sale	94.57	647	61,188	4,300	Mar 01 05:33 PM
Hoge Stephen	President	Feb 22 '24	Sale	100.00	15,000	1,500,000	1,513,433	Feb 23 04:04 PM
Bancel Stephane	Chief Executive Officer	Feb 16 '24	Sale	88.88	26,351	2,342,098	5,460,224	Feb 16 04:10 PM
Hoge Stephen	President	Feb 16 '24	Sale	88.88	10,542	936,981	1,528,433	Feb 16 04:19 PM
Hoge Stephen	President	Feb 12 '24	Sale	86.23	304	26,214	1,516,281	Feb 13 04:13 PM
Hoge Stephen	President	Jan 16 '24	Sale	103.90	15,000	1,558,500	1,516,063	Jan 17 04:12 PM
Mock James M	Chief Financial Officer	Jan 08 '24	Sale	109.75	772	84,731	3,632	Jan 09 04:08 PM
Hoge Stephen	President	Dec 27 '23	Sale	100.01	45,000	4,500,450	1,531,063	Dec 28 08:00 AM
Klinger Shannon Thyme	Chief Legal Officer	Dec 08 '23	Sale	79.09	563	44,525	7,912	Dec 11 04:03 PM
Garay Arpa	Chief Commercial Officer	Dec 06 '23	Sale	78.34	564	44,182	3,690	Dec 07 04:21 PM
Hoge Stephen	President	Dec 04 '23	Sale	79.31	309	24,508	1,576,063	Dec 05 04:07 PM
Klinger Shannon Thyme	Chief Legal Officer	Dec 04 '23	Sale	79.31	111	8,804	7,336	Dec 05 04:10 PM
Hoge Stephen	President	Nov 29 '23	Sale	79.81	1,136	90,666	1,575,721	Nov 30 04:11 PM
Hoge Stephen	President	Nov 10 '23	Sale	68.76	263	18,084	1,574,446	Nov 13 04:02 PM
AFEYAN NOUBAR	Director	Nov 01 '23	Sale	76.00	10,000	760,032	2,146,931	Nov 03 07:00 PM
AFEYAN NOUBAR	Director	Oct 25 '23	Sale	76.99	10,000	769,854	2,156,931	Oct 27 07:00 PM
AFEYAN NOUBAR	Director	Oct 11 '23	Sale	103.30	15,000	1,549,441	2,166,931	Oct 13 07:00 PM
Mock James M	Chief Financial Officer	Oct 06 '23	Sale	102.50	2,858	292,953	2,952	Oct 10 04:51 PM
AFEYAN NOUBAR	Director	Oct 04 '23	Sale	102.72	15,000	1,540,845	2,181,931	Oct 06 07:02 PM
AFEYAN NOUBAR	Director	Sep 27 '23	Sale	98.96	10,000	989,646	2,196,931	Sep 29 07:00 PM
AFEYAN NOUBAR	Director	Sep 20 '23	Sale	104.74	15,000	1,571,090	2,206,931	Sep 22 07:00 PM
Hoge Stephen	President	Sep 15 '23	Sale	112.99	15,000	1,694,850	1,574,187	Sep 18 04:06 PM
AFEYAN NOUBAR	Director	Sep 13 '23	Sale	109.70	15,000	1,645,522	2,221,931	Sep 15 07:00 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 08 '23	Sale	107.22	557	59,722	7,215	Sep 11 04:02 PM
AFEYAN NOUBAR	Director	Sep 06 '23	Sale	107.61	15,000	1,614,094	1,982,209	Sep 08 07:01 PM
Garay Arpa	Chief Commercial Officer	Sep 06 '23	Sale	108.40	574	62,219	3,113	Sep 07 04:46 PM
Hoge Stephen	President	Sep 05 '23	Sale	111.44	320	35,660	1,589,187	Sep 06 04:08 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 05 '23	Sale	111.44	115	12,815	6,634	Sep 06 04:17 PM
AFEYAN NOUBAR	Director	Aug 30 '23	Sale	115.46	15,000	1,731,951	1,997,209	Sep 01 07:00 PM
Hoge Stephen	President	Aug 29 '23	Sale	115.01	1,135	130,542	1,588,855	Aug 30 04:07 PM
AFEYAN NOUBAR	Director	Aug 23 '23	Sale	115.51	15,000	1,732,613	2,012,209	Aug 25 07:00 PM
Hoge Stephen	President	Aug 17 '23	Sale	100.00	15,000	1,500,000	1,587,579	Aug 18 05:16 PM
AFEYAN NOUBAR	Director	Aug 16 '23	Sale	97.56	10,000	975,614	2,027,209	Aug 18 07:01 PM
Hoge Stephen	President	Aug 10 '23	Sale	102.53	247	25,325	1,602,579	Aug 11 04:18 PM
AFEYAN NOUBAR	Director	Aug 02 '23	Sale	110.99	15,000	1,664,876	2,037,209	Aug 04 07:00 PM
AFEYAN NOUBAR	Director	Jul 26 '23	Sale	120.42	15,000	1,806,229	2,052,209	Jul 28 07:05 PM
AFEYAN NOUBAR	Director	Jul 19 '23	Sale	125.48	15,000	1,882,152	2,067,209	Jul 21 07:00 PM
Hoge Stephen	President	Jul 17 '23	Sale	120.60	15,000	1,809,000	1,602,303	Jul 18 04:35 PM
AFEYAN NOUBAR	Director	Jul 12 '23	Sale	125.81	15,000	1,887,081	2,082,209	Jul 14 07:01 PM
AFEYAN NOUBAR	Director	Jul 05 '23	Sale	124.73	15,000	1,870,933	2,097,209	Jul 07 07:00 PM
Bancel Stephane	Chief Executive Officer	Jun 28 '23	Option Exercise	0.99	27,155	26,883	5,439,101	Jun 30 04:51 PM
Bancel Stephane	Chief Executive Officer	Jun 28 '23	Sale	121.63	27,155	3,302,907	5,411,946	Jun 30 04:51 PM
AFEYAN NOUBAR	Director	Jun 28 '23	Sale	121.54	15,000	1,823,160	2,112,209	Jun 30 07:02 PM
Bancel Stephane	Chief Executive Officer	Jun 22 '23	Option Exercise	0.99	40,000	39,600	5,451,946	Jun 23 04:03 PM
Bancel Stephane	Chief Executive Officer	Jun 22 '23	Sale	119.41	40,000	4,776,427	5,411,946	Jun 23 04:03 PM
Bancel Stephane	Chief Executive Officer	Jun 21 '23	Option Exercise	0.99	40,000	39,600	5,451,946	Jun 23 04:03 PM
Bancel Stephane	Chief Executive Officer	Jun 21 '23	Sale	121.98	40,000	4,879,287	5,411,946	Jun 23 04:03 PM
AFEYAN NOUBAR	Director	Jun 21 '23	Sale	121.95	15,000	1,829,227	2,127,209	Jun 23 07:01 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

PACB

Pacific Biosciences of California Inc

MRNA

Moderna Inc

Upgrade your FINVIZ experience